A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MTD

Search Conditions:
Search Keyword : MTD
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: MTD
Appearance Frequency: 4942 time(s)
Long forms: 160

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
maximum tolerated dose
(4458 times)
Neoplasms
(2581 times)
DLT (1152 times)
DLTs (414 times)
PK (397 times)
1976 Problems in extrapolating toxicity data for laboratory animals to man.
muscle tension dysphonia
(70 times)
Otolaryngology
(53 times)
ADSD (12 times)
MPT (5 times)
EMG (3 times)
1983 Muscular tension dysphonia.
Mycobacterium Tuberculosis Direct Test
(61 times)
Microbiology
(23 times)
TB (9 times)
AFB (7 times)
CSF (6 times)
1993 Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test.
methadone
(28 times)
Chemistry Techniques, Analytical
(7 times)
EDDP (8 times)
MS (4 times)
COC (3 times)
1997 Enantioselective high-performance liquid chromatography determination of methadone enantiomers and its major metabolite in human biological fluids using a new derivatized cyclodextrin-bonded phase.
maximum tumor diameter
(26 times)
Neoplasms
(15 times)
RP (6 times)
PSA (5 times)
HR (4 times)
2001 Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors.
maximum transverse diameter
(14 times)
Vascular Diseases
(5 times)
AAA (4 times)
AB (2 times)
CT (2 times)
1990 [Comparison of classic and digital pelvimetry for measuring the medial transverse diameter in 50 female patients].
mean time to death
(14 times)
Virology
(4 times)
a.s (1 time)
BclA (1 time)
CNS (1 time)
1983 Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis.
mean tumor diameter
(14 times)
Neoplasms
(4 times)
LGGs (3 times)
TFI (3 times)
LGG (2 times)
1985 Histologic lesions in undescended ectopic obstructed testes.
metadynamics
(12 times)
Chemistry
(11 times)
CPMD (4 times)
FES (2 times)
MD (2 times)
2009 The effects of water on beta-D-xylose condensation reactions.
10  mannitol dehydrogenase
(10 times)
Botany
(4 times)
SA (2 times)
Gal (1 time)
Glc (1 time)
1996 Immunolocalization of mannitol dehydrogenase in celery plants and cells.
11  minimal topological difference
(10 times)
Chemistry
(4 times)
QSAR (6 times)
PLS (2 times)
CoMFA (1 time)
1980 Potential anticancer agents. XX. 1. Steric fit analysis in aromatic nitrogen mustards area.
12  mitochondrial targeting domain
(7 times)
Biochemistry
(3 times)
BH3 (2 times)
CPPs (1 time)
FAST (1 time)
2004 FAST is a BCL-X(L)-associated mitochondrial protein.
13  mean total dose
(6 times)
Neoplasms
(5 times)
CRPC (1 time)
CTV (1 time)
DFS (1 time)
1983 Adjuvant chemotherapy (CMF) for breast carcinoma. Patient's compliance and total dose achieved.
14  maxillary transverse deficiency
(5 times)
Dentistry
(4 times)
SARME (2 times)
AHI (1 time)
LARME (1 time)
2008 Surgically assisted rapid palatal expansion: a literature review.
15  minimum therapeutic dose
(5 times)
Pharmacology
(2 times)
ALP (1 time)
AMPs (1 time)
i.t (1 time)
2006 Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.
16  morbidity with temporary disability
(5 times)
Occupational Medicine
(4 times)
HD (1 time)
IHD (1 time)
1990 [Incidence of hypertension and ischemic heart disease with temporary disability among workers exposed to vibration].
17  maximum tumor dimension
(4 times)
Neoplasms
(2 times)
CT (1 time)
EXB (1 time)
HV (1 time)
2000 Assessment of morphometric measurements of prostate carcinoma volume.
18  mean tumor dose
(4 times)
Biophysics
(2 times)
MLD (4 times)
2014 SU-C-BRF-06: Impact of Temporal Probability in 4D Dose Calculation for Lung Cancer Treatment Planning.
19  minimal tanning dose
(4 times)
Dermatology
(4 times)
IPD (3 times)
MED (2 times)
LE (1 time)
1981 A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications.
20  minimum target dose
(4 times)
Neoplasms
(3 times)
MCD (2 times)
BED (1 time)
cc (1 time)
1999 The relationship between dose heterogeneity ("hot" spots) and complications following high-dose rate brachytherapy.
21  multiple threshold display
(4 times)
Diagnostic Imaging
(2 times)
SSD (3 times)
CT (1 time)
1994 [Preoperative assessment of aortic dissection by three-dimensional CT angiography].
22  myocardial tissue Doppler
(4 times)
Cardiology
(2 times)
LV (3 times)
IUGR (2 times)
IVS (2 times)
2007 [Normal values of the peak early diastolic Ea using myocardial tissue Doppler in 100 elite athletes].
23  2-methyl-1,3,4-thiadiazole-5-thiol
(3 times)
Pharmacology
(2 times)
MTT (3 times)
TPMT (2 times)
Vmax (1 time)
1985 Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol.
24  M. tuberculosis Direct Test
(3 times)
Microbiology
(2 times)
GTMD (1 time)
PCR (1 time)
TB (1 time)
2006 Comparison of real-time polymerase chain reaction using the Smart Cycler and the Gen-Probe amplified Mycobacterium tuberculosis direct test for detection of M. tuberculosis complex in clinical specimens.
25  macromolecule transduction domain
(3 times)
Neoplasms
(1 time)
CP-Parkin (1 time)
ES (1 time)
MPTP (1 time)
2013 Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells.
26  maximum temperature difference
(3 times)
Neoplasms
(1 time)
AAP (1 time)
ARH (1 time)
AT (1 time)
1989 Thermal conduction effects associated with temperature measurements in proximity to radiofrequency electrodes and microwave antennas.
27  mechanical thrombectomy device
(3 times)
Vascular Diseases
(2 times)
EBCs (1 time)
2009 The "GP" mechanical thrombectomy device.
28  meso-transdiene
(3 times)
Pharmacology
(2 times)
DAT (3 times)
nAChRs (2 times)
VMAT2 (2 times)
2005 Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.
29  methyldopa
(3 times)
Chemistry Techniques, Analytical
(2 times)
ATLD (1 time)
CBD (1 time)
CMWCNTs (1 time)
2010 Quantitative analysis of levodopa, carbidopa and methyldopa in human plasma samples using HPLC-DAD combined with second-order calibration based on alternating trilinear decomposition algorithm.
30  microtubule-targeting drug
(3 times)
Neoplasms
(1 time)
RCC (1 time)
SAR (1 time)
VHL (1 time)
2006 Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells.
31  minimal toxic dose
(3 times)
Pharmacology
(2 times)
CED (1 time)
PVC (1 time)
TR (1 time)
1989 Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys.
32  5,10-methylenetetrahydrofolate dehydrogenase
(2 times)
Biochemistry
(2 times)
yMTD (1 time)
1996 Crystallization of the NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase from Saccharomyces cerevisiae.
33  magnetic targeted drug delivery
(2 times)
Biology
(1 time)
DOX (2 times)
EDX (2 times)
PEG (2 times)
2014 Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
34  maintenance treatment with methadone
(2 times)
Drug Therapy
(2 times)
FLVX (2 times)
FX (1 time)
1994 Probable metabolic interaction between methadone and fluvoxamine in addict patients.
35  malignant trophoblastic disease
(2 times)
Neoplasms
(1 time)
--- 2010 Prevention of post-mole malignant trophoblastic disease with vitamin A.
36  maximal tumour debulking
(2 times)
General Surgery
(2 times)
CRS (2 times)
HIPEC (2 times)
CCRS (1 time)
2015 Risk of definitive stoma after surgery for peritoneal malignancy in 958 patients: comparative study between complete cytoreductive surgery and maximal tumor debulking.
37  maximum tolerated activities
(2 times)
Neoplasms
(2 times)
mAbs (2 times)
RIT (1 time)
1998 Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
38  maximum tolerated intravenous doses
(2 times)
Environmental Health
(1 time)
AmB (1 time)
DSHemsPC (1 time)
RBCPR (1 time)
2004 On the safety of reduced nicotinamide adenine dinucleotide (NADH).
39  mechanotransduction
(2 times)
Medicine
(2 times)
FA (1 time)
FAK (1 time)
MBD2 (1 time)
2014 Mechanical loading in osteocytes induces formation of a Src/Pyk2/MBD2 complex that suppresses anabolic gene expression.
40  membrane-targeting domain
(2 times)
Medical Informatics
(1 time)
FV (1 time)
HD (1 time)
HDD (1 time)
2012 A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.
41  Methylthiodeoxynivalenol
(2 times)
Biochemistry
(1 time)
DON (1 time)
2014 Methylthiodeoxynivalenol (MTD): insight into the chemistry, structure and toxicity of thia-Michael adducts of trichothecenes.
42  microfine titanium dioxide
(2 times)
Dermatology
(1 time)
2-EHMC (2 times)
DMBA (1 time)
UV (1 time)
1995 Sunscreen protection of contact hypersensitivity responses from chronic solar-simulated ultraviolet irradiation correlates with the absorption spectrum of the sunscreen.
43  minimal transactivation domain
(2 times)
Molecular Biology
(2 times)
HIF (1 time)
1998 Identification of N-terminal minimal transactivation domain of CBP, p300 and caenorhabditis elegans homologues.
44  mitochondrial debris
(2 times)
Medicine
(1 time)
mtDNA (2 times)
CLP (1 time)
DAMPs (1 time)
2015 Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents.
45  mitral valve-tricuspid valve distance
(2 times)
Medicine
(1 time)
--- 2007 Normal offset of the tricuspid septal leaflet in Thai fetuses.
46  mothers with typically developing children
(2 times)
Allergy and Immunology
(1 time)
MAU (2 times)
ASD (1 time)
2012 Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model.
47  moving target detection
(2 times)
Medical Informatics
(1 time)
ATR (1 time)
FPGA (1 time)
SAR (1 time)
1999 Signal subspace fusion of uncalibrated sensors with application in SAR and diagnostic medicine.
48  myofibroblastic transdifferentiation
(2 times)
Gastroenterology
(1 time)
PPARgamma (2 times)
DKK1 (1 time)
HSC (1 time)
2011 Epigenetic cell fate regulation of hepatic stellate cells.
49  2-mercapto-1,3,4-thiadiazole
(1 time)
Chemistry
(1 time)
DMEP (1 time)
MT (1 time)
PTOX (1 time)
2012 Novel biotransformation process of podophyllotoxin to 4 beta-sulfur-substituted podophyllum derivates with anti-tumor activity by Penicillium purpurogenum Y.J. Tang.
50  2-methyl-2,4-thiazolidine dicarboxylate
(1 time)
Biochemistry
(1 time)
--- 1977 The isolation and identification of 2-methyl-2,4-thiazolidine dicarboxylate as a by-product in the conversion of cysteine to glucose in the perfused rat liver.
51  4-methoxy-terphenyl-3″,5″-dimethanethiol
(1 time)
Chemistry
(1 time)
MTM (1 time)
NTD (1 time)
NTM (1 time)
2013 Self-assembly of mono- and bidentate oligoarylene thiols onto polycrystalline Au.
52  4-Methoxydalbergione
(1 time)
Neurology
(1 time)
COX-2 (1 time)
HMTD (1 time)
HO (1 time)
2017 Heme Oxygenase-1-Inducing Activity of 4-Methoxydalbergione and 4'-Hydroxy-4-methoxydalbergione from Dalbergia odorifera and Their Anti-inflammatory and Cytoprotective Effects in Murine Hippocampal and BV2 Microglial Cell Line and Primary Rat Microglial Cells.
53  magnetic tracking device
(1 time)
Orthopedics
(1 time)
--- 2009 Three-dimensional analysis of cervical spine motion: reliability of a computer assisted magnetic tracking device compared to inclinometer.
54  magnetotherapeutic device
(1 time)
Complementary Therapies
(1 time)
VAS (1 time)
2011 Effect of magnetotherapeutic device on pain associated with neck and shoulder stiffness.
55  mainly located in the distal colon
(1 time)
General Surgery
(1 time)
--- 1989 1,2-Dimethylhydrazine-induced carcinogenesis influenced by different colonic anastomoses in rats.
56  major thoracic duct
(1 time)
General Surgery
(1 time)
--- 1992 Management of chylothorax complicating extensive esophageal resection.
57  Making the Difference
(1 time)
Obesity
(1 time)
--- 2012 A qualitative evaluation of exposure to and perceptions of the Woolworths Healthy Tuck Shop Guide in Cape Town, South Africa.
58  mammalian transcriptomic database
(1 time)
Biology
(1 time)
--- 2017 MTD: a mammalian transcriptomic database to explore gene expression and regulation.
59  mammalian tumor-derived
(1 time)
Medicine
(1 time)
--- 2005 Pleomorphic mammalian tumor-derived bacteria self-organize as multicellular mammalian eukaryotic-like organisms: morphogenetic properties in vitro, possible origins, and possible roles in mammalian 'tumor ecologies'.
60  marginal target displacement
(1 time)
Biophysics
(1 time)
EPID (1 time)
RGRT (1 time)
TC (1 time)
2014 Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy.
61  maximal required/tolerated dose frequency
(1 time)
BCC (1 time)
iMTD (1 time)
2006 iMTD (individualized maximal tolerated dose) protocol: A clinical strategy to address interindividual heterogeneity to antiangiogenic therapy.
62  maximal target dose
(1 time)
Cardiology
(1 time)
Arg389Gly (1 time)
BB (1 time)
CI (1 time)
2016 Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study.
63  maximal threshold limit dose
(1 time)
Anatomy
(1 time)
--- 1977 [Effect of talliblastine on several hematologic indices].
64  maximal tolerable distension
(1 time)
Gastroenterology
(1 time)
IBS (1 time)
2001 Abdominal symptoms and anorectal function in health and irritable bowel syndrome.
65  maximal tolerated absorbed dose
(1 time)
Nuclear Medicine
(1 time)
AD (1 time)
SS (1 time)
VOI (1 time)
2017 3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma.
66  maximal total dose
(1 time)
Neoplasms
(1 time)
DVH (1 time)
EUD (1 time)
IMRT (1 time)
2005 The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.
67  maximal-tolerated daily dose
(1 time)
Neoplasms
(1 time)
AUC (1 time)
Cmax (1 time)
1998 Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.
68  Maximally tolerated dose of cinnabar
(1 time)
Complementary Therapies
(1 time)
ADI (1 time)
NOAEL (1 time)
2009 [Study on hepatoxicity and nephrotoxicity of cinnabar in rats].
69  maximally tolerated sublethal doses
(1 time)
Biochemistry
(1 time)
MTDs (1 time)
1988 Use of alternative dose schedules for the determination of sublethal doses of potential antiviral drugs in mice.
70  maximum safely tolerated dose
(1 time)
Neoplasms
(1 time)
ATP (1 time)
NCI (1 time)
1996 Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer.
71  maximum termination density
(1 time)
Neurology
(1 time)
aFGF (1 time)
BDA (1 time)
FR (1 time)
1997 Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts.
72  maximum threshold distances
(1 time)
Molecular Biology
(1 time)
--- 2014 Establishment and optimization of a regionally applicable maize gene-flow model.
73  Maximum Tolerable Dosage
(1 time)
Dentistry
(1 time)
--- 1987 Effects of fluoride on the mouse sperm morphology test.
74  maximum tolerated cyclophosphamide dose
(1 time)
Internal Medicine
(1 time)
--- 2006 A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma.
75  maximum tolerated decreases
(1 time)
Toxicology
(1 time)
ANC (1 time)
2007 CFU-GM assay for evaluation of drug myelotoxic activity.
76  maximum tolerated dose/injection
(1 time)
Neoplasms
(1 time)
--- 2003 IDN 5390: an oral taxane candidate for protracted treatment schedules.
77  maximum tolerated duration
(1 time)
Hematology
(1 time)
ASCT (1 time)
AUC (1 time)
DLT (1 time)
2007 Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.
78  maximum tolerated i.v. or i.p. doses
(1 time)
Antineoplastic Agents
(1 time)
--- 2001 A new prodrug of paclitaxel: synthesis of Protaxel.
79  maximum tolerated radiation absorbed dose
(1 time)
Endocrinology
(1 time)
MTA (1 time)
2006 The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer.
80  Maximum tolerated single, intraperitoneal doses
(1 time)
Genetics
(1 time)
--- 1990 Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
81  maximum tolerated therapy
(1 time)
Neoplasms
(1 time)
--- 2009 Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma.
82  maximum tolerated treatment dose
(1 time)
Allergy and Immunology
(1 time)
gamma-IFN (1 time)
1987 Phase I/II trial of recombinant gamma-interferon in patients with renal cell carcinoma: immunologic and biologic effects.
83  mealtime durations
(1 time)
Gastroenterology
(1 time)
LTC (1 time)
MIPs (1 time)
2017 How Swallow Pressures and Dysphagia Affect Malnutrition and Mealtime Outcomes in Long-Term Care.
84  mean reciprocal time to death
(1 time)
Microbiology
(1 time)
--- 1964 SINGLE-DOSE ASSAY TECHNIQUE FOR VARIOLA VIRUS.
85  mean thyroid dose
(1 time)
Neoplasms
(1 time)
HNSCC (1 time)
HT (1 time)
NTCP (1 time)
2013 Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction.
86  mean tissue density
(1 time)
Diagnostic Imaging
(1 time)
HT (1 time)
2004 Correlation of computerized gray-scale sonographic findings with thyroid function and thyroid autoimmune activity in patients with Hashimoto's thyroiditis.
87  mean total CMF dosages
(1 time)
General Surgery
(1 time)
--- 1982 Adjuvant chemotherapy (CMF) for breast carcinoma: hematological side effects.
88  Measurement-to-delivery
(1 time)
Biomedical Engineering
(1 time)
ANNs (1 time)
EMG (1 time)
PS (1 time)
2007 Identification of human term and preterm labor using artificial neural networks on uterine electromyography data.
89  mechanical tapping device
(1 time)
Dentistry
(1 time)
--- 2009 Potential damage to bone-implant interface when measuring initial implant stability.
90  mechanical transport drivers
(1 time)
Physical Medicine
(1 time)
AH (1 time)
PPT (1 time)
2014 [The effectiveness and safety of the balneotherapeutic treatment of the mechanical transport drivers suffering heart rhythm disorders].
91  medial tibial depth
(1 time)
Sports Medicine
(1 time)
ACL (1 time)
CTS (1 time)
LTS (1 time)
2016 Risk of Noncontact Anterior Cruciate Ligament Injuries Is Not Associated With Slope and Concavity of the Tibial Plateau in Recreational Alpine Skiers: A Magnetic Resonance Imaging-Based Case-Control Study of 121 Patients.
92  medial tibial plateau
(1 time)
Sports Medicine
(1 time)
ACL (1 time)
CTS (1 time)
LTS (1 time)
2016 Risk of Noncontact Anterior Cruciate Ligament Injuries Is Not Associated With Slope and Concavity of the Tibial Plateau in Recreational Alpine Skiers: A Magnetic Resonance Imaging-Based Case-Control Study of 121 Patients.
93  medial tibial plateau depth
(1 time)
Sports Medicine
(1 time)
ACL (1 time)
CTS (1 time)
2012 Tibial plateau geometry influences lower extremity biomechanics during landing.
94  median time to development
(1 time)
General Surgery
(1 time)
--- 2015 Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma.
95  Medical Treatment Duration
(1 time)
Health Services Research
(1 time)
CW (1 time)
MERS (1 time)
PRN (1 time)
2009 Prehospital pain treatment: an economic productivity factor in emergency medicine?
96  MedicelTulle Dressing
(1 time)
Nursing
(1 time)
--- 2008 Phase 2 study of a new Hydrofiber dressing for superficial chronic or acute wounds.
97  medium test dust
(1 time)
Pharmacology
(1 time)
--- 2013 Differentiation of subvisible silicone oil droplets from irregular standard dust particles.
98  mega-trend diffusion
(1 time)
Medical Informatics
(1 time)
KNN (1 time)
SVM (1 time)
2014 Prediction of human breast and colon cancers from imbalanced data using nearest neighbor and support vector machines.
99  melancholic depression and 'modern-type' depression
(1 time)
--- 2016 A comparison of perceptions of 'modern-type' and melancholic depression in Japan.
100  melphalan, thalidomide, and reduced intensity dexamethasone
(1 time)
Hematology
(1 time)
--- 2009 Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide.